Long-Term Follow-Up Study of Patients Receiving ATL001
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Melanoma
Related studies linked through entity extraction aliases.
A Phase I Study to Evaluate the Safety, Tolerability and Pharmacokinetics of JS004 in Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Study to Evaluate AB308 in Combination With AB122 in Participants With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
RPTR-168 in Patients With Human Papillomavirus Strain 16 (HPV-16) E6/E7 Positive Tumors and Melanoma
- Status
- TERMINATED
- Phase
- PHASE1
BESPOKE Study of ctDNA Guided Immunotherapy
- Status
- COMPLETED
- Phase
- N/A
MElanoma Research Lymph Node Prediction Implementation National_001
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
AI Augmented Training for Skin Specialists
- Status
- COMPLETED
- Phase
- NA
A Study of HX008 Plus LP002 for the Treatment of Patients With Advanced Melanoma
- Status
- UNKNOWN
- Phase
- PHASE1
BI-1808 as a Single Agent and With Pembrolizumab (KEYTRUDA® ) in Treatment of Advanced Malignancies(Keynote-D20)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
- Status
- RECRUITING
- Phase
- N/A
A Study of HX008 for the Treatment of Patients With Malignant Melanoma
- Status
- UNKNOWN
- Phase
- PHASE2
Clinical Application of 18F-PEG3-FPN PET Imaging in Diagnosis and Staging of Malignant Melanoma
- Status
- UNKNOWN
- Phase
- NA
A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
MAGE-C2 TCR T Cell Trial to Treat Melanoma and Head and Neck Cancer
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Family History App in Personalized Medicine
- Status
- COMPLETED
- Phase
- NA
A Clinical Trial Assessing BT-001 Alone and in Combination With Pembrolizumab in Metastatic or Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Combination or Sequence of Vemurafenib, Cobimetinib, and Atezolizumab in High-risk, Resectable Melanoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
DNX-2440 for Resectable Colorectal Liver Metastasis
- Status
- SUSPENDED
- Phase
- PHASE1
Substudy 02D: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents or Pembrolizumab Alone in Participants With Melanoma Brain Metastasis (MK-3475-02D/KEYMAKER-U02)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2